top of page

COVID-19 RESOURCES
Refer to this page for the latest educational resources and information on lenzilumab as a therapeutic for cytokine storm resulting from COVID-19 infection.
For information on Humanigen's Phase 3 Clinical Trial visit ClinicalTrials.gov (Identifier: NCT04351152)
bottom of page